Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Yupingfeng nasal irrigation is a modified traditional Chinese medicine (TCM) herbal formulation used as a nasal rinse for the treatment of allergic rhinitis and sinusitis. Developed by Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences, it is based on the classic Yupingfeng formula (typically containing Astragalus membranaceus, Atractylodes macrocephala, and Saposhnikovia divaricata) with additional herbs ("Jiawei") to enhance its therapeutic effect. The treatment is hypothesized to modulate the leukotriene pathway, thereby reducing nasal inflammation and symptoms associated with eosinophilic sinusitis and allergic rhinitis. In clinical studies, it has been compared against standard treatments like saline and budesonide nasal irrigations to evaluate its efficacy in modulating inflammatory pathways and improving patient outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiawei Yupingfeng nasal irrigation.